Type 2 diabetes and obesity induce similar transcriptional reprogramming in human myocytes

被引:33
作者
Varemo, Leif [1 ]
Henriksen, Tora Ida [2 ,3 ]
Scheele, Camilla [2 ,3 ,4 ]
Broholm, Christa [2 ,3 ]
Pedersen, Maria [2 ,3 ]
Uhlen, Mathias [5 ,6 ]
Pedersen, Bente Klarlund [2 ,3 ]
Nielsen, Jens [1 ,6 ]
机构
[1] Chalmers Univ Technol, Dept Biol & Biol Engn, S-41296 Gothenburg, Sweden
[2] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, DK-2100 Copenhagen O, Denmark
[3] Univ Copenhagen, Rigshosp, Ctr Phys Act Res, DK-2100 Copenhagen O, Denmark
[4] Univ Copenhagen, Ctr Basic Metab Res, Novo Nordisk Fdn, DK-2200 Copenhagen N, Denmark
[5] AlbaNova Univ Ctr, Royal Inst Technol KTH, Sch Biotechnol, Dept Prote, S-10691 Stockholm, Sweden
[6] Royal Inst Technol KTH, Sci Life Lab, S-17121 Stockholm, Sweden
来源
GENOME MEDICINE | 2017年 / 9卷
基金
新加坡国家研究基金会;
关键词
Type; 2; diabetes; Obesity; Skeletal myocytes; RNA-seq; Gene expression; Gene-set analysis; Metabolic network; DIFFERENTIAL EXPRESSION ANALYSIS; HUMAN SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; INSULIN SENSITIVITY; METABOLIC SYNDROME; DEVELOPMENTAL REGULATORS; GENE-EXPRESSION; RESISTANCE; DEFECTS; NETWORK;
D O I
10.1186/s13073-017-0432-2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Skeletal muscle is one of the primary tissues involved in the development of type 2 diabetes (T2D). The close association between obesity and T2D makes it difficult to isolate specific effects attributed to the disease alone. Therefore, here we set out to identify and characterize intrinsic properties of myocytes, associated independently with T2D or obesity. Methods: We generated and analyzed RNA-seq data from primary differentiated myotubes from 24 human subjects, using a factorial design (healthy/T2D and non-obese/obese), to determine the influence of each specific factor on genome-wide transcription. This setup enabled us to identify intrinsic properties, originating from muscle precursor cells and retained in the corresponding myocytes. Bioinformatic and statistical methods, including differential expression analysis, gene-set analysis, and metabolic network analysis, were used to characterize the different myocytes. Results: We found that the transcriptional program associated with obesity alone was strikingly similar to that induced specifically by T2D. We identified a candidate epigenetic mechanism, H3K27me3 histone methylation, mediating these transcriptional signatures. T2D and obesity were independently associated with dysregulated myogenesis, down-regulated muscle function, and up-regulation of inflammation and extracellular matrix components. Metabolic network analysis identified that in T2D but not obesity a specific metabolite subnetwork involved in sphingolipid metabolism was transcriptionally regulated. Conclusions: Our findings identify inherent characteristics in myocytes, as a memory of the in vivo phenotype, without the influence from a diabetic or obese extracellular environment, highlighting their importance in the development of T2D.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Gut microbiota is a factor of risk for obesity and type 2 diabetes
    Demidova, T. Y.
    Lobanova, K. G.
    Oinotkinova, O. S.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (10) : 97 - 104
  • [32] Adipokines: Role in the pathophysiology and therapy of obesity and type 2 diabetes
    Fasshauer, Mathias
    Blueher, Matthias
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2009, 33 (01): : 1 - 6
  • [33] T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes
    Touch, Sothea
    Clement, Karine
    Andre, Sebastien
    CURRENT DIABETES REPORTS, 2017, 17 (09)
  • [34] Metabolic reprogramming in type 2 diabetes and the development of breast cancer
    Martin, Sheree D.
    McGee, Sean L.
    JOURNAL OF ENDOCRINOLOGY, 2018, 237 (02) : R35 - R46
  • [35] The influence of carbohydrate quality on cardiovascular disease, the metabolic syndrome, type 2 diabetes, and obesity - an overview
    Slyper, Arnold H.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2013, 26 (7-8) : 617 - 629
  • [36] Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity
    Nolen-Doerr, Eric
    Stockman, Mary-Catherine
    Rizo, Ivania
    CURRENT OBESITY REPORTS, 2019, 8 (03) : 284 - 291
  • [37] The endocannabinoid system in obesity and type 2 diabetes
    Di Marzo, V.
    DIABETOLOGIA, 2008, 51 (08) : 1356 - 1367
  • [38] Epidemiology of childhood type 2 diabetes and obesity
    Shaw, Jonathan
    PEDIATRIC DIABETES, 2007, 8 : 7 - 15
  • [39] Role of Epigenetics in Type 2 Diabetes and Obesity
    Capparelli, Rosanna
    Iannelli, Domenico
    BIOMEDICINES, 2021, 9 (08)
  • [40] Complex impact of obesity on type 2 diabetes
    Raz, I
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2005, 7 (06): : 402 - 403